MENU
+Compare
SRPT
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$61.81
Change
+$2.32 (+3.90%)
Capitalization
5.99B

SRPT Sarepta Therapeutics Forecast, Technical & Fundamental Analysis

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases... Show more

Industry: #Biotechnology
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SRPT with price predictions
Apr 23, 2025

SRPT's RSI Oscillator ascending out of oversold territory

The RSI Indicator for SRPT moved out of oversold territory on April 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on SRPT as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SRPT just turned positive on April 14, 2025. Looking at past instances where SRPT's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRPT advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

SRPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SRPT entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.923) is normal, around the industry mean (14.056). P/E Ratio (26.393) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (3.503) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SRPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SRPT is expected to report earnings to rise 3.16% to $1.96 per share on April 30

Sarepta Therapeutics SRPT Stock Earnings Reports
Q1'25
Est.
$1.96
Q4'24
Beat
by $0.36
Q3'24
Beat
by $0.68
Q2'24
Beat
by $0.57
Q1'24
Beat
by $0.75
The last earnings report on February 26 showed earnings per share of $1.90, beating the estimate of $1.54. With 1.56M shares outstanding, the current market capitalization sits at 5.99B.
A.I. Advisor
published General Information

General Information

a developer of treatments for life-threatening illnesses and viruses

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
215 First Street
Phone
+1 617 274-4000
Employees
1314
Web
https://www.sarepta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIAX13.690.19
+1.41%
Nuveen DOW 30Sm Dynamic Overwrite Fund
FCPI41.430.57
+1.40%
Fidelity Stocks for Inflation ETF
PAB41.760.08
+0.19%
PGIM Active Aggregate Bond ETF
CGMU26.330.04
+0.15%
Capital Group Municipal Income ETF
MBBB20.87N/A
N/A
VanEck Mdy's Aly BBB Corp Bd ETF

SRPT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with GLMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+0.30%
GLMD - SRPT
51%
Loosely correlated
+11.63%
ALZN - SRPT
49%
Loosely correlated
N/A
TECX - SRPT
46%
Loosely correlated
+0.32%
INSM - SRPT
44%
Loosely correlated
-0.70%
AXON - SRPT
43%
Loosely correlated
+3.82%
More